Recent studies have shown that latent Epstein–Barr virus (EBV) infection can exacerbate immune evasion by increasing the number of Tregs and CTLA-4 tumor-infiltrating lymphocytes (TILs), as well as upregulating PD-1/PD-L1 expression. Here, PDCD1 is linked to neoplasm.